(2R,3S,7R,9S,10S,11R)-10-[(2S,3R,4S,6R)-4-二甲基氨基-3-羟基-6-甲基-四氢吡喃-2-基]氧基-2-乙基-3-羟基-3,7,9,11-四甲基-1-氧杂环十二碳-4-烯-6,12-二酮 | 497-72-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (2R,3S,7R,9S,10S,11R)-10-[(2S,3R,4S,6R)-4-二甲基氨基-3-羟基-6-甲基-四氢吡喃-2-基]氧基-2-乙基-3-羟基-3,7,9,11-四甲基-1-氧杂环十二碳-4-烯-6,12-二酮
• 英文名称: methymycin
• 英文别名: (3R,4S,5S,7R,9E,11S,12R)-4-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione
• CAS: 497-72-3
• 化学式: C₂₅H₄₃NO₇
• 分子量: 469.619
• InChiKey: HUKYPYXOBINMND-HYUJHOPRSA-N

物化性质

• 熔点：
  195.5-197°
• 比旋光度：
  D22 +61° (c = 0.7 in methanol), +74° (c = 1.1 in chloroform)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  33
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.84
• 拓扑面积：
  106
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  (2R,3S,7R,9S,10S,11R)-10-[(2S,3R,4S,6R)-4-二甲基氨基-3-羟基-6-甲基-四氢吡喃-2-基]氧基-2-乙基-3-羟基-3,7,9,11-四甲基-1-氧杂环十二碳-4-烯-6,12-二酮 在 甲醇 、 硫酸 作用下， 生成 α-甘露糖苷酶
  参考文献：
  名称：

  The Structure of the Antibiotic Methymycin¹

  摘要：

  DOI：

  10.1021/ja01605a026
• 作为产物：
  描述：

  YC-17 在 potassium dihydrogenphosphate 、 乙二胺四乙酸 、 还原型辅酶II(NADPH)四钠盐 作用下， 生成 (2R,3S,7R,9S,10S,11R)-10-[(2S,3R,4S,6R)-4-二甲基氨基-3-羟基-6-甲基-四氢吡喃-2-基]氧基-2-乙基-3-羟基-3,7,9,11-四甲基-1-氧杂环十二碳-4-烯-6,12-二酮
  参考文献：
  名称：

  Macrolide biosynthesis: A single cytochrome P450, PicK, is responsible for the hydroxylations that generate methymycin, neomethymycin, and picromycin in Streptomyces venezuelae

  摘要：

  The final step in the biosynthesis of methymycin, neomethymycin, and picromycin is an hydroxylation, shown to be carried out by the cytochrome P-450 monooxygenase, PicK. Direct comparison of the relative k(cat)/K-m values for the two substrates, YC-17 and narbomycin, showed a threefold rate preference of picK for narbomycin. (C) 1998 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(98)00553-8

文献信息

• [EN] ANTIBACTERIAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIBACTÉRIENS
  申请人：MASSACHUSETTS GEN HOSPITAL

  公开号：WO2019199979A1

  公开（公告）日：2019-10-17

  The present application provides compounds of formula: Methods of using these compounds for killing bacterial growth and treating bacterial infections are also provided.

  本申请提供了以下化合物的公式：还提供了使用这些化合物杀灭细菌生长和治疗细菌感染的方法。
• [EN] ANTIMICROBIAL AGENTS AND COMPOSITIONS AND USES THEREOF<br/>[FR] AGENTS ANTIMICROBIENS, COMPOSITIONS ASSOCIÉES ET LEURS UTILISATIONS
  申请人：CHEMIC LABORATORIES INC

  公开号：WO2021055506A1

  公开（公告）日：2021-03-25

  Described herein are compounds that act as antimicrobial agents, compositions comprising these compounds, and methods of their use in to treating infections caused by Helicobacter pylori (H. pylori) or killing or inhibititing the growth of H. pylori.

  本文描述了作为抗微生物剂的化合物，包括这些化合物的组合物，以及它们在治疗由幽门螺杆菌（H. pylori）引起的感染或杀灭或抑制幽门螺杆菌生长的方法。
• Method for Making Carbonates and Esters
  申请人：Belfadhel Hatem Abdallah

  公开号：US20100123097A1

  公开（公告）日：2010-05-20

  A method for forming a monomeric carbonate includes the step of combining a monofunctional alcohol or a difunctional diol with an ester-substituted diaryl carbonate to form a reaction mixture. Similarly, a method for forming a monomeric ester includes the step of combining a monofunctional carboxylic acid or ester with an ester-substituted diaryl carbonate to form a reaction mixture. These methods further include the step of allowing the reaction mixtures to react to form a monomeric carbonate or a monomeric ester, respectively.

  形成单体碳酸酯的方法包括将单官能醇或双官能二元醇与酯基取代的二芳基碳酸酯结合以形成反应混合物的步骤。类似地，形成单体酯的方法包括将单官能羧酸或酯与酯基取代的二芳基碳酸酯结合以形成反应混合物的步骤。这些方法进一步包括允许反应混合物反应以分别形成单体碳酸酯或单体酯的步骤。
• METHOD FOR PRODUCING AVENACIOLIDES AND USES THEREOF
  申请人：Academia Sinica

  公开号：US20160297829A1

  公开（公告）日：2016-10-13

  Disclosed herein are novel uses of avenaciolide derivatives and the preparation method of producing the same. The avenaciolide derivatives may suppress or inhibit the growth of gram-positive bacteria, including the notorious methicillin-resistant Staphylococcus aureus . Accordingly, the avenaciolides derivatives are potential lead compounds for the development of next generation antibiotics for the treatment of disease and/or disorders related to infection caused by gram-positive bacteria.

  本发明公开了avenaciolide衍生物的新用途及其制备方法。这些avenaciolide衍生物能够抑制或阻断革兰氏阳性细菌的生长，包括臭名昭著的耐甲氧西林金黄色葡萄球菌。因此，avenaciolide衍生物是开发下一代抗生素的潜在先导化合物，用于治疗由革兰氏阳性细菌引起的感染相关疾病和/或紊乱。
• 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
  申请人：Lee Ik Hyoung

  公开号：US20080031902A1

  公开（公告）日：2008-02-07

  Provided are 1-aryl-5-alkyl pyrazole compounds, of formula (I): wherein: R 1 is hydrogen, cyano, halogen, R 8 , formyl, —C(O)R 8 , —C(O)OR 8 , —C(O)NR 9 R 10 , or —C(S)NH 2 ; R 2 is R 2 or —S(O) m R 11 ; R 3 is methyl, ethyl or C 1 -C 4 haloalkyl; R 4 , R 5 and R 7 are independently hydrogen, halogen, alkyl, haloalkyl, cyano or nitro; R 6 is halogen, alkyl, haloalkyl, alkoxy, haloalkyloxy, cyano, nitro, —C(O)R 12 , —S(O) n R 12 or SF 5 ; Z is a nitrogen atom or C—R 13 ; R 8 is alkyl, haloalkyl, cycloalkyl or halocycloalkyl; R 9 is hydrogen, alkyl, haloalkyl or alkoxy; R 10 is hydrogen, alkyl, haloalkyl or alkoxy; R 11 is alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl or cycloalkyl; R 12 is alkyl or haloalkyl; R 13 is hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, alkoxy or haloalkoxy; m is 0, 1 or 2; and n is 0, 1 or 2; or a salt thereof, the method of making compounds of formula (I) and the use of these compounds against ectoparasites, endoparasites and pests.

  提供了1-芳基-5-烷基吡唑化合物，化学式为(I)：其中：R1为氢、氰基、卤素、R8、甲酰基、—C(O)R8、—C(O)OR8、—C(O)NR9R10或—C(S)NH2；R2为R2或—S(O)mR11；R3为甲基、乙基或C1-C4卤代烷基；R4、R5和R7独立地为氢、卤素、烷基、卤代烷基、氰基或硝基；R6为卤素、烷基、卤代烷基、烷氧基、卤代烷氧基、氰基、硝基、—C(O)R12、—S(O)nR12或SF5；Z为氮原子或C—R13；R8为烷基、卤代烷基、环烷基或卤代环烷基；R9为氢、烷基、卤代烷基或烷氧基；R10为氢、烷基、卤代烷基或烷氧基；R11为烷基、卤代烷基、烯基、卤代烯基、炔基、卤代炔基或环烷基；R12为烷基或卤代烷基；R13为氢、卤素、氰基、硝基、烷基、卤代烷基、烷氧基或卤代烷氧基；m为0、1或2；n为0、1或2；或其盐，制备化合物(I)的方法以及这些化合物对外寄生虫、内寄生虫和害虫的用途。